Come Learn About A-T Trials That Have Data To Share!
10.00 AM EST: Welcome and introductions by Cynthia Rothblum-Oviatt 10.05: David Coman: Triheptanoin - A trial in progress for A-T (recorded presentation) 10.20: Discussion (note this will not be Q&A style) 10.30: David Lynch: Omaveloxolone - Presentation of findings with Friedreich’s ataxia and insights on clinical trial design for rare diseases 10.55 Q&A and Discussion 11.10: Helena Donath: Potential biomarkers for A-T – NF-L and miRNA 11.25: Q&A and Discussion 11.35: Howard Lederman: Finding biomarkers for A-T – potential for an in-depth session 11.50: General discussion - Biomarkers 12.00: Last minute Q&A / Discussion for all speakers 12.30: Adjourn
After registering, you will receive a confirmation email containing information about joining the meeting. If you have any registration questions, please contact Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken. with the A-T Society.
A-TCRN Questions? Contact
Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken. | Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.